GPSM2 and Behcet disease: Our finding that lithium causes a marked inhibition of the rate of synthesis of PIns, and hence turnover of PIP2, without affecting steady-state levels refutes one of the main arguments against IMPase being a relevant primary therapeutic target of lithium in the treatment of BD.